Passage BIO (PASG) Operating Expenses (2019 - 2026)

Passage BIO has reported Operating Expenses for 8 years, with the latest figure at $10.2 million in Q2 2026.

• On a quarterly basis, Operating Expenses fell 1.14% year-over-year to $10.2 million in Q2 2026; TTM through Jun 2026 was $38.1 million, a 29.89% decrease from a year earlier, with the FY2025 full-year figure at $43.2 million, down 33.78% from the prior year.
• Operating Expenses was $10.2 million for Q2 2026 at Passage BIO, up from $8.9 million in the prior quarter.
• The five-year high for Operating Expenses was $41.3 million in Q1 2022, with the low at $8.7 million in Q3 2025.
• Average Operating Expenses over 5 years is $20.3 million, with a median of $17.5 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses advanced 10.36% in 2022, then sank 49.7% in 2024.
• Over 5 years, Operating Expenses stood at $28.2 million in 2022, then tumbled by 34.69% to $18.4 million in 2023, then declined by 22.64% to $14.3 million in 2024, then decreased by 27.54% to $10.3 million in 2025, then decreased by 1.2% to $10.2 million in 2026.
• The last three Operating Expenses figures came in at $10.2 million (Q2 2026), $8.9 million (Q1 2026), and $10.3 million (Q4 2025), per Business Quant data.